KIM, LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
KIM, LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$4,541
-99.9%
450,0000.0%0.25%
+20.7%
Q3 2022$4,460,000
+1.0%
450,0000.0%0.21%
-1.9%
Q2 2022$4,415,000–450,000–0.21%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders